Chemoinformaics analysis of 2,3,5-Trimethyldecane
Molecular Weight | 184.367 | nRot | 7 |
Heavy Atom Molecular Weight | 156.143 | nRig | 7 |
Exact Molecular Weight | 184.219 | nRing | 0 |
Solubility: LogS | -0.623 | nHRing | 0 |
Solubility: LogP | 1.177 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 40.3802 |
nHD | 0 | BPOL | 28.0898 |
QED | 0.597 |
Synth | 1.573 |
Natural Product Likeliness | -0.981 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.144 |
MDCK | 0.0000372 |
BBB | 0.936 |
PPB | 0.553449 |
VDSS | 1.332 |
FU | 0.440436 |
CYP1A2-inh | 0.964 |
CYP1A2-sub | 0.542 |
CYP2c19-inh | 0.522 |
CYP2c19-sub | 0.463 |
CYP2c9-inh | 0.086 |
CYP2c9-sub | 0.291 |
CYP2d6-inh | 0.117 |
CYP2d6-sub | 0.249 |
CYP3a4-inh | 0.203 |
CYP3a4-sub | 0.263 |
CL | 12.229 |
T12 | 0.811 |
hERG | 0.057 |
Ames | 0.013 |
ROA | 0.098 |
SkinSen | 0.766 |
Carcinogencity | 0.165 |
EI | 0.987 |
Respiratory | 0.069 |
NR-Aromatase | 0.063 |
Antiviral | Yes |
Prediction | 0.6052 |